TrialBMC ophthalmology2025

Longitudinal safety and efficacy of dual treatment with orthokeratology lenses and 0.01% atropine eye drops: a focus on epithelial changes and tear film stability.

Fabiao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.